These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4755634)

  • 1. Raman spectroscopic evidence for two conformations of uncomplexed valinomycin in the solid state.
    Rothschild KJ; Asher IM; Anastassakis E; Stanley HE
    Science; 1973 Oct; 182(4110):384-6. PubMed ID: 4755634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the lipid environment on valinomycin structure and cation complex formation.
    Halsey CM; Benham DA; JiJi RD; Cooley JW
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():200-6. PubMed ID: 22683555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Models of ionic transport in biological membranes. Raman spectroscopy as a probe of valinomycin, gramicidin A', and rhodopsin conformations.
    Rothschild KJ; Stanley HE
    Am J Clin Pathol; 1975 May; 63(5):695-713. PubMed ID: 48337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular structure and mechanisms of action of cyclic and linear ion transport antibiotics.
    Duax WL; Griffin JF; Langs DA; Smith GD; Grochulski P; Pletnev V; Ivanov V
    Biopolymers; 1996; 40(1):141-55. PubMed ID: 8541445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UVRR spectroscopic studies of valinomycin complex formation in different solvents.
    Ozdemir A; Lednev IK; Asher SA
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):19-26. PubMed ID: 15556416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformations of an ion-binding cyclic peptide analogue of valinomycin, cyclo(L-Val-Gly-Gly-L-Pro)3.
    Easwaran KR; Pease LG; Blout ER
    Biochemistry; 1979 Jan; 18(1):61-7. PubMed ID: 420778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of a valinomycin-hexaaquamagnesium trifluoromethanesulfonate compound.
    Fujita M; Kazerouni AM; Bacsa J
    Acta Crystallogr C Struct Chem; 2016 Aug; 72(Pt 8):627-33. PubMed ID: 27487337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raman spectroscopic study of the valinomycin--KSCN complex.
    Asher IM; Rothschild KJ; Stanley HE
    J Mol Biol; 1974 Oct; 89(1):205-22. PubMed ID: 4444048
    [No Abstract]   [Full Text] [Related]  

  • 9. Valinomycin crystal structure determination by direct methods.
    Duax WL; Hauptman H; Weeks CM; Norton DA
    Science; 1972 May; 176(4037):911-4. PubMed ID: 5033632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the conformations of valinomycin in solution phase.
    Wang F; Zhao C; Polavarapu PL
    Biopolymers; 2004 Sep; 75(1):85-93. PubMed ID: 15307200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raman spectroscopy of uncomplexed valinomycin. 2. Nonpolar and polar solution.
    Rothschild KJ; Asher IM; Stanley HE; Anastassakis E
    J Am Chem Soc; 1977 Mar; 99(7):2032-9. PubMed ID: 864130
    [No Abstract]   [Full Text] [Related]  

  • 12. Raman spectroscopy of uncomplexed valinomycin. I. The solid state.
    Asher IM; Rothschild KJ; Anastassakis E; Stanley HE
    J Am Chem Soc; 1977 Mar; 99(7):2024-32. PubMed ID: 864129
    [No Abstract]   [Full Text] [Related]  

  • 13. Valinomycin and its interaction with ions in organic solvents, detergents, and lipids studied by Fourier transform IR spectroscopy.
    Jackson M; Mantsch HH
    Biopolymers; 1991 Sep; 31(10):1205-12. PubMed ID: 1790298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solvent-dependent conformations of valinomycin in solution.
    Patel DJ; Tonelli AE
    Biochemistry; 1973 Jan; 12(3):486-96. PubMed ID: 4683491
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring the backbone conformation of valinomycin by Raman optical activity.
    Yamamoto S; Watarai H; Bouř P
    Chemphyschem; 2011 Jun; 12(8):1509-18. PubMed ID: 21384485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of valinomycin by molecular dynamics studies.
    Shobana S; Vishveshwara S
    Indian J Biochem Biophys; 1991; 28(5-6):363-8. PubMed ID: 1812068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular conformation of a D,L stereoisomeric analogue of valinomycin, cyclo[-(L-Val-L-Hyi-L-Val-D-Hyi)2-(D-Val-L-Hyi-L-Val-D-Hyi)-].
    Langs DA; Grochulski P; Duax WL; Pletnev VZ; Ivanov VT
    Biopolymers; 1991 Mar; 31(4):417-23. PubMed ID: 1863693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Crystallization and molecular structure of cyclic dodecadepsipeptide cyclo]D-Val-D-Hyi-Val-Hyi-(D-Val-Hyi-Val-D-Hyi)2-].2C3H60].
    Pletnev VZ; Tsygannik IN; Mikhaĭlova IIu; Ivanov VT; Lengs DA; Grokhul'skiĭ P; Diuéks VL
    Bioorg Khim; 1991 Mar; 17(3):359-71. PubMed ID: 2064628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution conformation of peptides by the intramolecular nuclear Overhauser effect experiment. Study of valinomycin-K+.
    Krishna NR; Agresti DG; Glickson JD; Walter R
    Biophys J; 1978 Dec; 24(3):791-814. PubMed ID: 737287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Envisaging Structural Insight of a Terminally Protected Proline Dipeptide by Raman Spectroscopy and Density Functional Theory Analyses.
    Das S; Pal U; Chatterjee M; Pramanik SK; Banerji B; Maiti NC
    J Phys Chem A; 2016 Dec; 120(49):9829-9840. PubMed ID: 27973793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.